Persistent high levels of carcinoembryonic antigen after tumor resection are associated with poorer survival outcomes in patients with resected colon cancer

被引:4
作者
Munoz-Montano, Wendy R. [1 ]
Lopez-Basave, Horacio N. [1 ]
Castillo-Morales, Alison [1 ]
Castillo-Morales, Carolina [1 ]
Sanchez-Trejo, Karen [2 ]
Catalan, Rodrigo [1 ]
Diaz-Romero, Consuelo [1 ]
Lino-Silva, Leonardo S. [1 ]
Maliachi-Diaz, Andrea [1 ]
Ruiz-Garcia, Erika [1 ]
Herrera-Martinez, Marytere [1 ]
Calderillo-Ruiz, German [1 ]
机构
[1] Inst Nacl Cancerol, Dept Med Oncol, Av San Fernando 22,Belisario Dominguez Secc 16, Mexico City 14080, Mexico
[2] Mexican Agcy Evaluat Hlth Technol, Mexico City, Mexico
关键词
CEA values; Pre-operative and post-surgical; Colon cancer; COLORECTAL-CANCER; FOLLOW-UP; RECURRENCE; MARKERS; CEA;
D O I
10.1186/s12885-023-11126-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundInterindividual survival and recurrence rates in cases of locoregional colon cancer following surgical resection are highly variable. The aim of the present study was to determine whether elevated pre-operative and post-operative CEA values are useful prognostic biomarkers for patients with stage I-III colon cancer who underwent surgery with curative intent.MethodsWe conducted a retrospective study in patients with histologically confirmed stage I-III primary colonic adenocarcinoma who underwent radical surgical resection at Mexico's National Cancer Institute, between January 2008 and January 2020. We determined pre-operative and post-operative CEA and analyzed the association of scores with poorer survival outcomes in patients with resected colon cancer, considering overall survival (OS) and disease-free survival (DFS).ResultsWe included 640 patients with stage I-III colon cancer. Pre-operative CEA levels were in the normal range in 460 patients (group A) and above the reference value in the other 180. Of the latter, 134 presented normalized CEA levels after surgery, but 46 (group C) continued to show CEA levels above the reference values after surgery. Therefore, propensity score matching (PSM) was carried out to reduce the bias. Patients were adjusted at a 1:1:1 ratio with 46 in each group, to match the number in the smallest group. Median follow- up was 46.4 months (range, 4.9-147.4 months). Median DFS was significantly shorter in Group C: 55.5 months (95% CI 39.6-71.3) than in the other two groups [Group A: 77.1 months (95% CI 72.6-81.6). Group B: 75.7 months (95% CI 66.8-84.5) (p-value < 0.001)]. Overall survival was also significantly worse in group C [57.1 (95% CI 37.8-76.3) months] than in group A [82.8 (95% CI 78.6-86.9 months] and group B [87.1 (95% CI 79.6-94.5 months] (p-value = 0.002). To identify whether change in CEA levels operative and post-surgery was an independent prognostic factor for survival outcomes, a Cox proportional hazard model was applied. In multivariate analysis, change in CEA level was a statistically significant, independent prognostic factor for overall survival (p-value = 0.031).ConclusionsWhen assessed collectively, pre-operative and post-operative CEA values are useful biomarkers for predicting survival outcomes in patients with resected colon cancer. Prognoses are worse for patients with elevated pre-operative and post-surgical CEA values, but similar in patients with normal post-surgical values, regardless of their pre-surgery values.
引用
收藏
页数:13
相关论文
共 23 条
[11]   Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update [J].
Duffy, M. J. ;
Lamerz, R. ;
Haglund, C. ;
Nicolini, A. ;
Kalousova, M. ;
Holubec, L. ;
Sturgeon, C. .
INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (11) :2513-2522
[12]   A Novel Prognostic Model Incorporating Carcinoembryonic Antigen in 3-Week or Longer Postoperative Period for Stage III Colon Cancer: A Multicenter Retrospective Study [J].
Fan, Jin ;
Liu, Yanlong ;
Cai, Xin ;
Wang, Jingwen ;
Guo, Rui ;
Ji, Yuan ;
Li, Chao ;
Xu, Ye ;
Li, Xinxiang ;
Zhang, Chundong ;
Zhang, Rui ;
Zhu, Ji ;
Cai, Sanjun .
FRONTIERS IN ONCOLOGY, 2020, 10
[13]   DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES [J].
GOLD, P ;
FREEDMAN, SO .
JOURNAL OF EXPERIMENTAL MEDICINE, 1965, 121 (03) :439-+
[14]   Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer [J].
Goldstein, MJ ;
Mitchell, EP .
CANCER INVESTIGATION, 2005, 23 (04) :338-351
[15]   Prognostic value of carcinoembryonic antigen levels before and after curative surgery in colon cancer patients [J].
Kim, Hyun Ryung ;
Joo, Jeong Il ;
Lim, Sang Woo ;
Oh, Bo Young .
ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2021, 100 (01) :33-39
[16]   Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome [J].
Konishi, Tsuyoshi ;
Shimada, Yoshifumi ;
Hsu, Meier ;
Tufts, Lauren ;
Jimenez-Rodriguez, Rosa ;
Cercek, Andrea ;
Yaeger, Rona ;
Saltz, Leonard ;
Smith, J. Joshua ;
Nash, Garrett M. ;
Guillem, Jose G. ;
Paty, Philip B. ;
Garcia-Aguilar, Julio ;
Gonen, Mithat ;
Weiser, Martin R. .
JAMA ONCOLOGY, 2018, 4 (03) :309-315
[17]   Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer [J].
Lin, Jen-Kou ;
Lin, Chun-Chi ;
Yang, Shung-Haur ;
Wang, Huann-Sheng ;
Jiang, Jeng-Kai ;
Lan, Yuan-Tzu ;
Lin, Tzu-Chen ;
Li, Anna Fen-Yau ;
Chen, Wei-Shone ;
Chang, Shih-Ching .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2011, 26 (09) :1135-1141
[18]   ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer [J].
Locker, Gershon Y. ;
Hamilton, Stanley ;
Harris, Jules ;
Jessup, John M. ;
Kemeny, Nancy ;
Macdonald, John S. ;
Somerfield, Mark R. ;
Hayes, Daniel F. ;
Bast, Robert C., Jr. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (33) :5313-5327
[19]   Effect of 3 to 5 Years of Scheduled CEA and CT Follow-up to Detect Recurrence of Colorectal Cancer The FACS Randomized Clinical Trial [J].
Primrose, John N. ;
Perera, Rafael ;
Gray, Alastair ;
Rose, Peter ;
Fuller, Alice ;
Corkhill, Andrea ;
George, Steve ;
Mant, David .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (03) :263-270
[20]  
Soerjomataram I., 2018, Global cancer observatory: cancer today